IP Library Granted Patent US 8,263,100
Granted Patent B2
US 8,263,100 · App. 12/529,430 · Granted Sep 11, 2012

Silver-containing foam structure

Assignee: Mölnlycke Health Care AB
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,263,100
App. No.
12/529,430
Granted
Sep 11, 2012
Kind
B2
Abstract

A method of producing a hydrophilic polyurethane foam structure containing a silver salt, chosen from the group of silver sulphate, silver citrate, silver acetate, silver carbonate, silver lactate and silver phosphate, or a mixture of these salts includes the steps of (a) providing a water phase containing a surfactant, and at least one silver salt, wherein the at least one silver salt is dispersed in the water phase; (b) providing a isocyanate-terminated polyether having functionality of more than (2); (c) mixing the water phase and the isocyanate-terminated polyether, immediately transferring the resulting mixture to a mould whereby a foam structure is obtained; and (d) drying the foam structure until it has a moisture content of at most 10% (wt). The hydrophilic polyurethane foam structure produced by the method and a wound dressing containing the foam structure are also described.

Claims (11)

1. A method of producing an antibacterial and hydrophilic polyurethane foam structure comprising the steps of

a) providing a water phase comprising a surfactant and a silver salt, wherein the silver salt comprises silver sulphate, silver citrate, silver acetate, silver carbonate, silver lactate, or silver phosphate, or a mixture thereof, and wherein a part of the silver salt is dispersed in the water phase;

b) providing an isocyanate-terminated polyether having a functionality of more than 2;

c) mixing said water phase and said isocyanate-terminated polyether, and immediately transferring the resulting mixture to a mould wherein the hydrophilic polyurethane foam structure is formed in the mould; and

d) drying said foam structure, wherein the dried foam structure has a moisture content of at most 10% by weight.

2. The method of claim 1 , wherein said mould is lined with casting paper before step c) and wherein said casting paper is removed before step d).

3. The method of claim 2 , wherein the method further comprises adding one or more gel-forming silicone components to one surface of the hydrophilic polyurethane foam foam structure obtained after step d) in the presence of a catalyst, wherein said gel-forming components form a cross-linked silicone gel by curing.

4. The method of claim 1 , wherein the method further comprises adding one or more gel-forming silicone components to one surface of the hydrophilic polyurethane foam structure obtained after step d) in the presence of a catalyst, wherein said gel-forming components form a cross-linked silicone gel by curing.

5. The method of claim 4 , wherein said catalyst comprises a platinum complex.

6. The method of claim 1 , wherein the dried hydrophilic polyurethane foam structure has at most 8% moisture content by weight.

7. The method of claim 1 , wherein the dried hydrophilic polyurethane foam structure has at most 5% moisture content by weight.

Assignments (2)
SECURITY AGREEMENT Recorded Nov 5, 2012
From: MOLNLYCKE HEALTH CARE AB
To: MORGAN STANLEY BANK INTERNATIONAL LIMITED
Reel/Frame 029244/0301 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2010
From: ARESKOUG, STEFAN; JOHANNISON, ULF; PRYDZ, MALIN
To: MOLNLYCKE HEALTH CARE AB
Reel/Frame 024107/0060 →
Priority Claims (1)
EP 07004275 · Mar 1, 2007 · regional
Continuity (1)
Related Publication 20100196501A1 · Aug 5, 2010